nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP1A2—chronic obstructive pulmonary disease	0.505	1	CbGaD
Imiquimod—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0576	0.257	CbGbCtD
Imiquimod—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0468	0.209	CbGbCtD
Imiquimod—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0316	0.141	CbGbCtD
Imiquimod—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0302	0.135	CbGbCtD
Imiquimod—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0269	0.12	CbGbCtD
Imiquimod—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0158	0.0705	CbGbCtD
Imiquimod—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0149	0.0666	CbGbCtD
Imiquimod—TLR8—respiratory system—chronic obstructive pulmonary disease	0.00623	0.49	CbGeAlD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—LY96—chronic obstructive pulmonary disease	0.00342	0.0471	CbGpPWpGaD
Imiquimod—TLR8—lung—chronic obstructive pulmonary disease	0.00331	0.26	CbGeAlD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—SFTPD—chronic obstructive pulmonary disease	0.00292	0.0402	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—LY96—chronic obstructive pulmonary disease	0.00267	0.0368	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—LY96—chronic obstructive pulmonary disease	0.00264	0.0364	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—LY96—chronic obstructive pulmonary disease	0.00259	0.0357	CbGpPWpGaD
Imiquimod—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00243	0.0335	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—SFTPD—chronic obstructive pulmonary disease	0.00221	0.0305	CbGpPWpGaD
Imiquimod—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00213	0.0293	CbGpPWpGaD
Imiquimod—TLR7—lung—chronic obstructive pulmonary disease	0.00209	0.164	CbGeAlD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—LY96—chronic obstructive pulmonary disease	0.00202	0.0279	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—LY96—chronic obstructive pulmonary disease	0.002	0.0276	CbGpPWpGaD
Imiquimod—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00188	0.0259	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TLR2—chronic obstructive pulmonary disease	0.00155	0.0214	CbGpPWpGaD
Imiquimod—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00154	0.0212	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TLR2—chronic obstructive pulmonary disease	0.00121	0.0167	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—TLR2—chronic obstructive pulmonary disease	0.0012	0.0165	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TLR2—chronic obstructive pulmonary disease	0.00118	0.0162	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TLR4—chronic obstructive pulmonary disease	0.00096	0.0132	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TLR2—chronic obstructive pulmonary disease	0.000919	0.0127	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—TLR2—chronic obstructive pulmonary disease	0.000908	0.0125	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—LY96—chronic obstructive pulmonary disease	0.000855	0.0118	CbGpPWpGaD
Imiquimod—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00078	0.0107	CbGpPWpGaD
Imiquimod—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000775	0.0107	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TLR4—chronic obstructive pulmonary disease	0.000749	0.0103	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—TLR4—chronic obstructive pulmonary disease	0.000741	0.0102	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TLR4—chronic obstructive pulmonary disease	0.000727	0.01	CbGpPWpGaD
Imiquimod—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000708	0.0557	CbGeAlD
Imiquimod—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00066	0.00909	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—CXCL8—chronic obstructive pulmonary disease	0.000651	0.00896	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—LY96—chronic obstructive pulmonary disease	0.000648	0.00893	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL1B—chronic obstructive pulmonary disease	0.000624	0.0086	CbGpPWpGaD
Imiquimod—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000601	0.00828	CbGpPWpGaD
Imiquimod—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000598	0.00824	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TLR4—chronic obstructive pulmonary disease	0.000568	0.00782	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—TLR4—chronic obstructive pulmonary disease	0.000561	0.00773	CbGpPWpGaD
Imiquimod—TLR8—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000512	0.00705	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—CXCL8—chronic obstructive pulmonary disease	0.000508	0.007	CbGpPWpGaD
Imiquimod—TLR8—Immune System—LY96—chronic obstructive pulmonary disease	0.000498	0.00686	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—CXCL8—chronic obstructive pulmonary disease	0.000493	0.00679	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL1B—chronic obstructive pulmonary disease	0.000487	0.00671	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL1B—chronic obstructive pulmonary disease	0.000473	0.00652	CbGpPWpGaD
Imiquimod—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000464	0.00639	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TNF—chronic obstructive pulmonary disease	0.000453	0.00624	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000448	0.00617	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—chronic obstructive pulmonary disease	0.000419	0.00577	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—IL6—chronic obstructive pulmonary disease	0.000411	0.00567	CbGpPWpGaD
Imiquimod—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000403	0.00555	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—IL6—chronic obstructive pulmonary disease	0.000397	0.00547	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000388	0.00535	CbGpPWpGaD
Imiquimod—TLR7—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000388	0.00535	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—CXCL8—chronic obstructive pulmonary disease	0.000385	0.0053	CbGpPWpGaD
Imiquimod—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000379	0.00522	CbGpPWpGaD
Imiquimod—TLR7—Immune System—LY96—chronic obstructive pulmonary disease	0.000377	0.0052	CbGpPWpGaD
Imiquimod—CYP1A2—lung—chronic obstructive pulmonary disease	0.000376	0.0296	CbGeAlD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL1B—chronic obstructive pulmonary disease	0.000369	0.00509	CbGpPWpGaD
Imiquimod—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000367	0.00505	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL6—chronic obstructive pulmonary disease	0.000366	0.00504	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000365	0.00503	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000364	0.00501	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TNF—chronic obstructive pulmonary disease	0.000354	0.00487	CbGpPWpGaD
Imiquimod—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000351	0.00483	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000345	0.00475	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TNF—chronic obstructive pulmonary disease	0.000343	0.00473	CbGpPWpGaD
Imiquimod—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000337	0.00464	CbGpPWpGaD
Imiquimod—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000324	0.00446	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—chronic obstructive pulmonary disease	0.000318	0.00437	CbGpPWpGaD
Imiquimod—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000317	0.00437	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—IL6—chronic obstructive pulmonary disease	0.000312	0.00429	CbGpPWpGaD
Imiquimod—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000305	0.0042	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—chronic obstructive pulmonary disease	0.000301	0.00414	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000294	0.00405	CbGpPWpGaD
Imiquimod—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000293	0.00403	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	0.000285	0.00393	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	0.000282	0.00389	CbGpPWpGaD
Imiquimod—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000281	0.00387	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL6—chronic obstructive pulmonary disease	0.000277	0.00382	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000277	0.00381	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000274	0.00377	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TNF—chronic obstructive pulmonary disease	0.000268	0.00369	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000267	0.00367	CbGpPWpGaD
Imiquimod—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000266	0.00367	CbGpPWpGaD
Imiquimod—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000251	0.00346	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.00025	0.00345	CbGpPWpGaD
Imiquimod—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000245	0.00337	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.00024	0.0033	CbGpPWpGaD
Imiquimod—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000236	0.00325	CbGpPWpGaD
Imiquimod—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000235	0.00324	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TLR2—chronic obstructive pulmonary disease	0.000226	0.00311	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00022	0.00304	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	0.000216	0.00298	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	0.000214	0.00295	CbGpPWpGaD
Imiquimod—TLR8—Immune System—KL—chronic obstructive pulmonary disease	0.000213	0.00293	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000207	0.00286	CbGpPWpGaD
Imiquimod—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000202	0.00109	CcSEcCtD
Imiquimod—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000202	0.00109	CcSEcCtD
Imiquimod—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000202	0.00109	CcSEcCtD
Imiquimod—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.00109	CcSEcCtD
Imiquimod—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00108	CcSEcCtD
Imiquimod—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.00108	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00108	CcSEcCtD
Imiquimod—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.0002	0.00108	CcSEcCtD
Imiquimod—Cough—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00107	CcSEcCtD
Imiquimod—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00106	CcSEcCtD
Imiquimod—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00106	CcSEcCtD
Imiquimod—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00106	CcSEcCtD
Imiquimod—Infection—Formoterol—chronic obstructive pulmonary disease	0.000197	0.00106	CcSEcCtD
Imiquimod—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.00106	CcSEcCtD
Imiquimod—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00105	CcSEcCtD
Imiquimod—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00105	CcSEcCtD
Imiquimod—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00105	CcSEcCtD
Imiquimod—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000195	0.00105	CcSEcCtD
Imiquimod—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00104	CcSEcCtD
Imiquimod—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00104	CcSEcCtD
Imiquimod—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.00104	CcSEcCtD
Imiquimod—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000194	0.00104	CcSEcCtD
Imiquimod—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000194	0.00104	CcSEcCtD
Imiquimod—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000194	0.00104	CcSEcCtD
Imiquimod—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00104	CcSEcCtD
Imiquimod—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00104	CcSEcCtD
Imiquimod—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00104	CcSEcCtD
Imiquimod—Infection—Montelukast—chronic obstructive pulmonary disease	0.000193	0.00104	CcSEcCtD
Imiquimod—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000192	0.00103	CcSEcCtD
Imiquimod—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.00103	CcSEcCtD
Imiquimod—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000192	0.00103	CcSEcCtD
Imiquimod—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00102	CcSEcCtD
Imiquimod—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00019	0.00102	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.00019	0.00261	CbGpPWpGaD
Imiquimod—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000188	0.00101	CcSEcCtD
Imiquimod—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.001	CcSEcCtD
Imiquimod—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.000998	CcSEcCtD
Imiquimod—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000185	0.00255	CbGpPWpGaD
Imiquimod—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000184	0.000989	CcSEcCtD
Imiquimod—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.000988	CcSEcCtD
Imiquimod—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.000987	CcSEcCtD
Imiquimod—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.000985	CcSEcCtD
Imiquimod—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.00098	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000182	0.0025	CbGpPWpGaD
Imiquimod—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.000976	CcSEcCtD
Imiquimod—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000181	0.000971	CcSEcCtD
Imiquimod—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.000971	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00018	0.000969	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00018	0.000969	CcSEcCtD
Imiquimod—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.000962	CcSEcCtD
Imiquimod—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000179	0.000962	CcSEcCtD
Imiquimod—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.000958	CcSEcCtD
Imiquimod—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000178	0.000956	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000177	0.000949	CcSEcCtD
Imiquimod—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.000949	CcSEcCtD
Imiquimod—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000176	0.000949	CcSEcCtD
Imiquimod—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.000946	CcSEcCtD
Imiquimod—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000176	0.000946	CcSEcCtD
Imiquimod—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000175	0.000943	CcSEcCtD
Imiquimod—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000174	0.000937	CcSEcCtD
Imiquimod—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.000937	CcSEcCtD
Imiquimod—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000174	0.000936	CcSEcCtD
Imiquimod—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000173	0.000933	CcSEcCtD
Imiquimod—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000173	0.00238	CbGpPWpGaD
Imiquimod—Injury—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000927	CcSEcCtD
Imiquimod—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000172	0.000926	CcSEcCtD
Imiquimod—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000172	0.000924	CcSEcCtD
Imiquimod—TLR7—Immune System—TLR2—chronic obstructive pulmonary disease	0.000171	0.00236	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD8A—chronic obstructive pulmonary disease	0.000171	0.00236	CbGpPWpGaD
Imiquimod—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000171	0.000919	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.000919	CcSEcCtD
Imiquimod—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000171	0.000917	CcSEcCtD
Imiquimod—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000171	0.000917	CcSEcCtD
Imiquimod—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.000917	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.000915	CcSEcCtD
Imiquimod—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00091	CcSEcCtD
Imiquimod—Pain—Formoterol—chronic obstructive pulmonary disease	0.000169	0.00091	CcSEcCtD
Imiquimod—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.000909	CcSEcCtD
Imiquimod—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.000902	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000167	0.0009	CcSEcCtD
Imiquimod—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000167	0.000898	CcSEcCtD
Imiquimod—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.000896	CcSEcCtD
Imiquimod—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.000893	CcSEcCtD
Imiquimod—Pain—Montelukast—chronic obstructive pulmonary disease	0.000166	0.000891	CcSEcCtD
Imiquimod—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000891	CcSEcCtD
Imiquimod—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000165	0.000889	CcSEcCtD
Imiquimod—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.000886	CcSEcCtD
Imiquimod—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.000886	CcSEcCtD
Imiquimod—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.000884	CcSEcCtD
Imiquimod—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000884	CcSEcCtD
Imiquimod—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000164	0.000881	CcSEcCtD
Imiquimod—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000164	0.000881	CcSEcCtD
Imiquimod—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.000878	CcSEcCtD
Imiquimod—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.000877	CcSEcCtD
Imiquimod—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000163	0.000877	CcSEcCtD
Imiquimod—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000163	0.00224	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000163	0.00224	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000163	0.00224	CbGpPWpGaD
Imiquimod—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000163	0.000876	CcSEcCtD
Imiquimod—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.000873	CcSEcCtD
Imiquimod—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000873	CcSEcCtD
Imiquimod—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000162	0.000872	CcSEcCtD
Imiquimod—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00087	CcSEcCtD
Imiquimod—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00087	CcSEcCtD
Imiquimod—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000869	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.000867	CcSEcCtD
Imiquimod—TLR7—Immune System—KL—chronic obstructive pulmonary disease	0.000161	0.00222	CbGpPWpGaD
Imiquimod—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.000866	CcSEcCtD
Imiquimod—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000161	0.00221	CbGpPWpGaD
Imiquimod—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.000859	CcSEcCtD
Imiquimod—TLR8—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000159	0.0022	CbGpPWpGaD
Imiquimod—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000159	0.00219	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000158	0.000852	CcSEcCtD
Imiquimod—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000157	0.000845	CcSEcCtD
Imiquimod—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.000845	CcSEcCtD
Imiquimod—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.000841	CcSEcCtD
Imiquimod—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000156	0.000841	CcSEcCtD
Imiquimod—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.000841	CcSEcCtD
Imiquimod—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000156	0.000841	CcSEcCtD
Imiquimod—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000156	0.000838	CcSEcCtD
Imiquimod—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000155	0.000831	CcSEcCtD
Imiquimod—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000154	0.00083	CcSEcCtD
Imiquimod—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000154	0.00083	CcSEcCtD
Imiquimod—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000154	0.000828	CcSEcCtD
Imiquimod—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.000828	CcSEcCtD
Imiquimod—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000154	0.000826	CcSEcCtD
Imiquimod—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000153	0.000824	CcSEcCtD
Imiquimod—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000153	0.000824	CcSEcCtD
Imiquimod—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000822	CcSEcCtD
Imiquimod—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.000821	CcSEcCtD
Imiquimod—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000152	0.0021	CbGpPWpGaD
Imiquimod—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.000815	CcSEcCtD
Imiquimod—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000813	CcSEcCtD
Imiquimod—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.000811	CcSEcCtD
Imiquimod—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.000798	CcSEcCtD
Imiquimod—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.000794	CcSEcCtD
Imiquimod—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.000794	CcSEcCtD
Imiquimod—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.000784	CcSEcCtD
Imiquimod—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000146	0.000784	CcSEcCtD
Imiquimod—TLR8—Immune System—CRP—chronic obstructive pulmonary disease	0.000146	0.00201	CbGpPWpGaD
Imiquimod—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000146	0.000783	CcSEcCtD
Imiquimod—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000145	0.000782	CcSEcCtD
Imiquimod—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000143	0.00197	CbGpPWpGaD
Imiquimod—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000143	0.000768	CcSEcCtD
Imiquimod—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.000763	CcSEcCtD
Imiquimod—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000142	0.000763	CcSEcCtD
Imiquimod—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.000753	CcSEcCtD
Imiquimod—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00014	0.000753	CcSEcCtD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00014	0.00193	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TLR4—chronic obstructive pulmonary disease	0.00014	0.00192	CbGpPWpGaD
Imiquimod—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000139	0.000748	CcSEcCtD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000138	0.0019	CbGpPWpGaD
Imiquimod—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.00074	CcSEcCtD
Imiquimod—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000137	0.000737	CcSEcCtD
Imiquimod—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.000728	CcSEcCtD
Imiquimod—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000135	0.000728	CcSEcCtD
Imiquimod—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000725	CcSEcCtD
Imiquimod—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000721	CcSEcCtD
Imiquimod—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000717	CcSEcCtD
Imiquimod—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000133	0.000713	CcSEcCtD
Imiquimod—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000711	CcSEcCtD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.00181	CbGpPWpGaD
Imiquimod—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.000706	CcSEcCtD
Imiquimod—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000131	0.000704	CcSEcCtD
Imiquimod—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.000704	CcSEcCtD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.00179	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD8A—chronic obstructive pulmonary disease	0.00013	0.00179	CbGpPWpGaD
Imiquimod—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000128	0.000689	CcSEcCtD
Imiquimod—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.000687	CcSEcCtD
Imiquimod—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000678	CcSEcCtD
Imiquimod—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.000676	CcSEcCtD
Imiquimod—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000126	0.000676	CcSEcCtD
Imiquimod—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.00173	CbGpPWpGaD
Imiquimod—Rash—Formoterol—chronic obstructive pulmonary disease	0.000125	0.000671	CcSEcCtD
Imiquimod—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.000671	CcSEcCtD
Imiquimod—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00067	CcSEcCtD
Imiquimod—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00067	CcSEcCtD
Imiquimod—Headache—Formoterol—chronic obstructive pulmonary disease	0.000124	0.000667	CcSEcCtD
Imiquimod—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.000667	CcSEcCtD
Imiquimod—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.000664	CcSEcCtD
Imiquimod—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000123	0.000663	CcSEcCtD
Imiquimod—Rash—Montelukast—chronic obstructive pulmonary disease	0.000122	0.000657	CcSEcCtD
Imiquimod—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000122	0.000656	CcSEcCtD
Imiquimod—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.000655	CcSEcCtD
Imiquimod—Depression—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000655	CcSEcCtD
Imiquimod—Headache—Montelukast—chronic obstructive pulmonary disease	0.000121	0.000653	CcSEcCtD
Imiquimod—TLR7—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000121	0.00166	CbGpPWpGaD
Imiquimod—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000647	CcSEcCtD
Imiquimod—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000645	CcSEcCtD
Imiquimod—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000644	CcSEcCtD
Imiquimod—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000644	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—EGFR—chronic obstructive pulmonary disease	0.000119	0.00164	CbGpPWpGaD
Imiquimod—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.000639	CcSEcCtD
Imiquimod—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000637	CcSEcCtD
Imiquimod—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000633	CcSEcCtD
Imiquimod—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000633	CcSEcCtD
Imiquimod—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000633	CcSEcCtD
Imiquimod—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000632	CcSEcCtD
Imiquimod—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000632	CcSEcCtD
Imiquimod—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.000629	CcSEcCtD
Imiquimod—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000621	CcSEcCtD
Imiquimod—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000619	CcSEcCtD
Imiquimod—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000612	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000113	0.00156	CbGpPWpGaD
Imiquimod—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.00061	CcSEcCtD
Imiquimod—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.000111	0.00153	CbGpPWpGaD
Imiquimod—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000597	CcSEcCtD
Imiquimod—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000594	CcSEcCtD
Imiquimod—TLR7—Immune System—CRP—chronic obstructive pulmonary disease	0.00011	0.00152	CbGpPWpGaD
Imiquimod—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000592	CcSEcCtD
Imiquimod—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000589	CcSEcCtD
Imiquimod—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000579	CcSEcCtD
Imiquimod—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000576	CcSEcCtD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.00147	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TLR4—chronic obstructive pulmonary disease	0.000106	0.00146	CbGpPWpGaD
Imiquimod—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000567	CcSEcCtD
Imiquimod—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000562	CcSEcCtD
Imiquimod—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000557	CcSEcCtD
Imiquimod—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000551	CcSEcCtD
Imiquimod—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000102	0.00141	CbGpPWpGaD
Imiquimod—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000547	CcSEcCtD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.0014	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.0001	0.00138	CbGpPWpGaD
Imiquimod—Angiopathy—Prednisone—chronic obstructive pulmonary disease	9.94e-05	0.000535	CcSEcCtD
Imiquimod—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	9.9e-05	0.000532	CcSEcCtD
Imiquimod—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	9.79e-05	0.000526	CcSEcCtD
Imiquimod—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.69e-05	0.000521	CcSEcCtD
Imiquimod—Alopecia—Prednisone—chronic obstructive pulmonary disease	9.69e-05	0.000521	CcSEcCtD
Imiquimod—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.62e-05	0.000517	CcSEcCtD
Imiquimod—Mental disorder—Prednisone—chronic obstructive pulmonary disease	9.6e-05	0.000516	CcSEcCtD
Imiquimod—Erythema—Prednisone—chronic obstructive pulmonary disease	9.54e-05	0.000513	CcSEcCtD
Imiquimod—Malnutrition—Prednisone—chronic obstructive pulmonary disease	9.54e-05	0.000513	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.39e-05	0.00129	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.28e-05	0.00128	CbGpPWpGaD
Imiquimod—Pain—Prednisolone—chronic obstructive pulmonary disease	9.16e-05	0.000493	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—IL6—chronic obstructive pulmonary disease	9.14e-05	0.00126	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL1B—chronic obstructive pulmonary disease	9.09e-05	0.00125	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—EGFR—chronic obstructive pulmonary disease	9.01e-05	0.00124	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	9.01e-05	0.00124	CbGpPWpGaD
Imiquimod—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	8.85e-05	0.000476	CcSEcCtD
Imiquimod—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.83e-05	0.000475	CcSEcCtD
Imiquimod—Agitation—Prednisone—chronic obstructive pulmonary disease	8.77e-05	0.000471	CcSEcCtD
Imiquimod—Angioedema—Prednisone—chronic obstructive pulmonary disease	8.72e-05	0.000469	CcSEcCtD
Imiquimod—Malaise—Prednisone—chronic obstructive pulmonary disease	8.6e-05	0.000463	CcSEcCtD
Imiquimod—Syncope—Prednisone—chronic obstructive pulmonary disease	8.56e-05	0.00046	CcSEcCtD
Imiquimod—Urticaria—Prednisolone—chronic obstructive pulmonary disease	8.51e-05	0.000458	CcSEcCtD
Imiquimod—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	8.39e-05	0.000451	CcSEcCtD
Imiquimod—Convulsion—Prednisone—chronic obstructive pulmonary disease	8.27e-05	0.000444	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.24e-05	0.00114	CbGpPWpGaD
Imiquimod—Hypertension—Prednisone—chronic obstructive pulmonary disease	8.24e-05	0.000443	CcSEcCtD
Imiquimod—Arthralgia—Prednisone—chronic obstructive pulmonary disease	8.12e-05	0.000437	CcSEcCtD
Imiquimod—Myalgia—Prednisone—chronic obstructive pulmonary disease	8.12e-05	0.000437	CcSEcCtD
Imiquimod—Anxiety—Prednisone—chronic obstructive pulmonary disease	8.09e-05	0.000435	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	8.07e-05	0.000434	CcSEcCtD
Imiquimod—Discomfort—Prednisone—chronic obstructive pulmonary disease	8.03e-05	0.000432	CcSEcCtD
Imiquimod—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.89e-05	0.000425	CcSEcCtD
Imiquimod—Oedema—Prednisone—chronic obstructive pulmonary disease	7.79e-05	0.000419	CcSEcCtD
Imiquimod—Infection—Prednisone—chronic obstructive pulmonary disease	7.74e-05	0.000416	CcSEcCtD
Imiquimod—Shock—Prednisone—chronic obstructive pulmonary disease	7.66e-05	0.000412	CcSEcCtD
Imiquimod—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	7.64e-05	0.000411	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	7.63e-05	0.00105	CbGpPWpGaD
Imiquimod—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.6e-05	0.000409	CcSEcCtD
Imiquimod—Skin disorder—Prednisone—chronic obstructive pulmonary disease	7.56e-05	0.000407	CcSEcCtD
Imiquimod—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	7.53e-05	0.000405	CcSEcCtD
Imiquimod—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.42e-05	0.000399	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.25e-05	0.000998	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.17e-05	0.000987	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	7.09e-05	0.000381	CcSEcCtD
Imiquimod—Dizziness—Prednisolone—chronic obstructive pulmonary disease	7.09e-05	0.000381	CcSEcCtD
Imiquimod—Insomnia—Prednisone—chronic obstructive pulmonary disease	7.04e-05	0.000379	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	7e-05	0.000965	CbGpPWpGaD
Imiquimod—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.99e-05	0.000376	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—IL6—chronic obstructive pulmonary disease	6.93e-05	0.000954	CbGpPWpGaD
Imiquimod—TLR8—Immune System—EGFR—chronic obstructive pulmonary disease	6.93e-05	0.000954	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL1B—chronic obstructive pulmonary disease	6.89e-05	0.000949	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	6.87e-05	0.000946	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	6.87e-05	0.000946	CbGpPWpGaD
Imiquimod—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.000369	CcSEcCtD
Imiquimod—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.77e-05	0.000364	CcSEcCtD
Imiquimod—Rash—Prednisolone—chronic obstructive pulmonary disease	6.76e-05	0.000363	CcSEcCtD
Imiquimod—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.75e-05	0.000363	CcSEcCtD
Imiquimod—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.71e-05	0.000361	CcSEcCtD
Imiquimod—Headache—Prednisolone—chronic obstructive pulmonary disease	6.71e-05	0.000361	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.6e-05	0.000909	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	6.54e-05	0.000901	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	6.54e-05	0.000901	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.51e-05	0.000897	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.42e-05	0.000884	CbGpPWpGaD
Imiquimod—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.42e-05	0.000345	CcSEcCtD
Imiquimod—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.37e-05	0.000342	CcSEcCtD
Imiquimod—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.37e-05	0.000342	CcSEcCtD
Imiquimod—Urticaria—Prednisone—chronic obstructive pulmonary disease	6.19e-05	0.000333	CcSEcCtD
Imiquimod—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	6.16e-05	0.000331	CcSEcCtD
Imiquimod—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	6.16e-05	0.000331	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.02e-05	0.00083	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.98e-05	0.000824	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.94e-05	0.000818	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.9e-05	0.000813	CbGpPWpGaD
Imiquimod—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.74e-05	0.000308	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.67e-05	0.000781	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.59e-05	0.00077	CbGpPWpGaD
Imiquimod—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.59e-05	0.0003	CcSEcCtD
Imiquimod—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.51e-05	0.000296	CcSEcCtD
Imiquimod—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.33e-05	0.000286	CcSEcCtD
Imiquimod—TLR8—Immune System—IL6—chronic obstructive pulmonary disease	5.32e-05	0.000733	CbGpPWpGaD
Imiquimod—TLR7—Immune System—EGFR—chronic obstructive pulmonary disease	5.25e-05	0.000723	CbGpPWpGaD
Imiquimod—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.15e-05	0.000277	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.02e-05	0.000692	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.96e-05	0.000683	CbGpPWpGaD
Imiquimod—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.95e-05	0.000266	CcSEcCtD
Imiquimod—Rash—Prednisone—chronic obstructive pulmonary disease	4.91e-05	0.000264	CcSEcCtD
Imiquimod—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.91e-05	0.000264	CcSEcCtD
Imiquimod—Headache—Prednisone—chronic obstructive pulmonary disease	4.88e-05	0.000262	CcSEcCtD
Imiquimod—Nausea—Prednisone—chronic obstructive pulmonary disease	4.63e-05	0.000249	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.62e-05	0.000636	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	4.56e-05	0.000628	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.55e-05	0.000627	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.38e-05	0.000603	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.32e-05	0.000595	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6—chronic obstructive pulmonary disease	4.03e-05	0.000556	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.52e-05	0.000485	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.25e-05	0.000448	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.02e-05	0.000416	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.94e-05	0.000405	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.73e-05	0.000377	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.33e-05	0.000321	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.27e-05	0.000313	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.18e-05	0.0003	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.11e-05	0.000291	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.61e-05	0.000221	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.59e-05	0.000219	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.48e-05	0.000204	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.45e-05	0.0002	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.24e-05	0.000171	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.23e-05	0.000169	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.12e-05	0.000154	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.11e-05	0.000153	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.1e-05	0.000151	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.03e-05	0.000142	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.02e-05	0.000141	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.7e-06	0.000134	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.59e-06	0.000118	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.47e-06	0.000117	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.9e-06	0.000109	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.49e-06	0.000103	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	6.59e-06	9.08e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	6.31e-06	8.69e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.09e-06	7.01e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.87e-06	6.7e-05	CbGpPWpGaD
